216 related articles for article (PubMed ID: 33072961)
1. Performance of the Four-Plex Tandem Mass Spectrometry Lysosomal Storage Disease Newborn Screening Test: The Necessity of Adding a 2nd Tier Test for Pompe Disease.
Chiang SC; Chen PW; Hwu WL; Lee AJ; Chen LC; Lee NC; Chiou LY; Chien YH
Int J Neonatal Screen; 2018 Dec; 4(4):41. PubMed ID: 33072961
[TBL] [Abstract][Full Text] [Related]
2. Newborn screening for lysosomal storage disorders by tandem mass spectrometry in North East Italy.
Burlina AB; Polo G; Salviati L; Duro G; Zizzo C; Dardis A; Bembi B; Cazzorla C; Rubert L; Zordan R; Desnick RJ; Burlina AP
J Inherit Metab Dis; 2018 Mar; 41(2):209-219. PubMed ID: 29143201
[TBL] [Abstract][Full Text] [Related]
3. Pilot study of newborn screening for six lysosomal storage diseases using Tandem Mass Spectrometry.
Elliott S; Buroker N; Cournoyer JJ; Potier AM; Trometer JD; Elbin C; Schermer MJ; Kantola J; Boyce A; Turecek F; Gelb MH; Scott CR
Mol Genet Metab; 2016 Aug; 118(4):304-9. PubMed ID: 27238910
[TBL] [Abstract][Full Text] [Related]
4. Identification of infants at risk for developing Fabry, Pompe, or mucopolysaccharidosis-I from newborn blood spots by tandem mass spectrometry.
Scott CR; Elliott S; Buroker N; Thomas LI; Keutzer J; Glass M; Gelb MH; Turecek F
J Pediatr; 2013 Aug; 163(2):498-503. PubMed ID: 23465405
[TBL] [Abstract][Full Text] [Related]
5. Multiplex newborn screening for Pompe, Fabry, Hunter, Gaucher, and Hurler diseases using a digital microfluidic platform.
Sista RS; Wang T; Wu N; Graham C; Eckhardt A; Winger T; Srinivasan V; Bali D; Millington DS; Pamula VK
Clin Chim Acta; 2013 Sep; 424():12-8. PubMed ID: 23660237
[TBL] [Abstract][Full Text] [Related]
6. Newborn screening for Morquio disease and other lysosomal storage diseases: results from the 8-plex assay for 70,000 newborns.
Chien YH; Lee NC; Chen PW; Yeh HY; Gelb MH; Chiu PC; Chu SY; Lee CH; Lee AR; Hwu WL
Orphanet J Rare Dis; 2020 Feb; 15(1):38. PubMed ID: 32014045
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Second-Tier Tests in Newborn Screening for Lysosomal Disorders in North Eastern Italy.
Burlina AB; Polo G; Rubert L; Gueraldi D; Cazzorla C; Duro G; Salviati L; Burlina AP
Int J Neonatal Screen; 2019 Jun; 5(2):24. PubMed ID: 33072983
[TBL] [Abstract][Full Text] [Related]
8. Newborn Screening of 6 Lysosomal Storage Disorders by Tandem Mass Spectrometry.
Chen Y; Yang Y; Zeng Y; Lin Q; Zhao P; Mao B; Qiu X; Huang T; Xu L; Zhu W
Clin Pediatr (Phila); 2023 Dec; ():99228231219336. PubMed ID: 38135922
[TBL] [Abstract][Full Text] [Related]
9. Evaluation, in a highly specialised enzyme laboratory, of a digital microfluidics platform for rapid assessment of lysosomal enzyme activity in dried blood spots.
Hirachan R; Horman A; Burke D; Heales S
JIMD Rep; 2024 Mar; 65(2):124-131. PubMed ID: 38444576
[TBL] [Abstract][Full Text] [Related]
10. Detecting multiple lysosomal storage diseases by tandem mass spectrometry--a national newborn screening program in Taiwan.
Liao HC; Chiang CC; Niu DM; Wang CH; Kao SM; Tsai FJ; Huang YH; Liu HC; Huang CK; Gao HJ; Yang CF; Chan MJ; Lin WD; Chen YJ
Clin Chim Acta; 2014 Apr; 431():80-6. PubMed ID: 24513544
[TBL] [Abstract][Full Text] [Related]
11. Establishment of Cutoff Values for Newborn Screening of Six Lysosomal Storage Disorders by Tandem Mass Spectrometry.
Li R; Tian L; Gao Q; Guo Y; Li G; Li Y; Sun M; Yan Y; Li Q; Nie W; Zou H
Front Pediatr; 2022; 10():814461. PubMed ID: 35419325
[TBL] [Abstract][Full Text] [Related]
12. Newborn screening for six lysosomal storage disorders in a cohort of Mexican patients: Three-year findings from a screening program in a closed Mexican health system.
Navarrete-Martínez JI; Limón-Rojas AE; Gaytán-García MJ; Reyna-Figueroa J; Wakida-Kusunoki G; Delgado-Calvillo MDR; Cantú-Reyna C; Cruz-Camino H; Cervantes-Barragán DE
Mol Genet Metab; 2017 May; 121(1):16-21. PubMed ID: 28302345
[TBL] [Abstract][Full Text] [Related]
13. Lysosomal storage disorder screening implementation: findings from the first six months of full population pilot testing in Missouri.
Hopkins PV; Campbell C; Klug T; Rogers S; Raburn-Miller J; Kiesling J
J Pediatr; 2015 Jan; 166(1):172-7. PubMed ID: 25444528
[TBL] [Abstract][Full Text] [Related]
14. Lysosomal storage disorder 4+1 multiplex assay for newborn screening using tandem mass spectrometry: application to a small-scale population study for five lysosomal storage disorders.
Orsini JJ; Martin MM; Showers AL; Bodamer OA; Zhang XK; Gelb MH; Caggana M
Clin Chim Acta; 2012 Aug; 413(15-16):1270-3. PubMed ID: 22548856
[TBL] [Abstract][Full Text] [Related]
15. Cut-off values of neonatal lysosomal storage disease-related enzymes detected by tandem mass spectrometry.
Li G; Tian L; Guo Y; Li Y; Sun M; Zou H
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Jun; 51(3):321-325. PubMed ID: 35462462
[TBL] [Abstract][Full Text] [Related]
16. A Roadmap for Potential Improvement of Newborn Screening for Inherited Metabolic Diseases Following Recent Developments and Successful Applications of Bivariate Normal Limits for Pre-Symptomatic Detection of MPS I, Pompe Disease, and Krabbe Disease.
Jalal K; Carter RL; Barczykowski A; Tomatsu S; Langan TJ
Int J Neonatal Screen; 2022 Nov; 8(4):. PubMed ID: 36412587
[TBL] [Abstract][Full Text] [Related]
17. Report of Five Years of Experience in Neonatal Screening for Mucopolysaccharidosis Type I and Review of the Literature.
Gragnaniello V; Gueraldi D; Rubert L; Manzoni F; Cazzorla C; Giuliani A; Polo G; Salviati L; Burlina A
Int J Neonatal Screen; 2020 Nov; 6(4):. PubMed ID: 33147872
[TBL] [Abstract][Full Text] [Related]
18. Tandem mass spectrometry-based multiplex assays for α-mannosidosis and fucosidosis.
Kumar AB; Hong X; Yi F; Wood T; Gelb MH
Mol Genet Metab; 2019 Jul; 127(3):207-211. PubMed ID: 31235216
[TBL] [Abstract][Full Text] [Related]
19. Direct multiplex assay of enzymes in dried blood spots by tandem mass spectrometry for the newborn screening of lysosomal storage disorders.
Gelb MH; Turecek F; Scott CR; Chamoles NA
J Inherit Metab Dis; 2006; 29(2-3):397-404. PubMed ID: 16763908
[TBL] [Abstract][Full Text] [Related]
20. Newborn screening for Pompe disease by measuring acid alpha-glucosidase activity using tandem mass spectrometry.
Dajnoki A; Mühl A; Fekete G; Keutzer J; Orsini J; Dejesus V; Zhang XK; Bodamer OA
Clin Chem; 2008 Oct; 54(10):1624-9. PubMed ID: 18703766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
